Atlas Trials

Phase I/II NabPaclitaxel, Paclitaxel&Carboplatin w RTX Followed by Consolidation in Patients w Favorable Prognosis Inoperable Stage IIIA/B NSCLC

Clinical trial NCT01757288 · COMPLETED

Trial details

NCT number
NCT01757288
Sponsor
University of Texas Southwestern Medical Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
STAGE IIIA/B NSCLC / INOPERABLE LUNG CANCER
Start date
2013-03-25
Primary completion
2019-06-03
Enrollment
98

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.